TY - JOUR AU - Hosono, M. a. k. o. t. o. AU - Ikebuchi, H. i. d. e. h. a. r. u. AU - Nakamura, Y. o. s. h. i. h. i. d. e. AU - Yanagida, S. a. c. h. i. k. o. AU - Kinuya, S. e. i. g. o. PY - 2018 DA - 2018// TI - Introduction of the targeted alpha therapy (with Radium-223) into clinical practice in Japan: learnings and implementation JO - Annals of Nuclear Medicine VL - 33 UR - https://doi.org/10.1007/s12149-018-1317-1 DO - 10.1007/s12149-018-1317-1 ID - Hosono2018 ER - TY - JOUR AU - Dauer, L. T. AU - Williamson, M. J. AU - Humm, J. AU - O’Donoghue, J. AU - Ghani, R. AU - Awadallah, R. PY - 2014 DA - 2014// TI - Radiation safety considerations for the use of 223RaCl2 de in men with castration-resistant prostate cancer JO - Health Phys. VL - 106 UR - https://doi.org/10.1097/HP.0b013e3182a82b37 DO - 10.1097/HP.0b013e3182a82b37 ID - Dauer2014 ER - TY - JOUR AU - Yamamoto, S. AU - Kato, K. AU - Fujita, N. AU - Yamashita, M. AU - Nishimoto, T. AU - Kameyama, H. PY - 2018 DA - 2018// TI - Detection of alpha radionuclides in air from patients during Ra-223 alpha radionuclide therapy JO - Sci Rep. VL - 8 UR - https://doi.org/10.1038/s41598-018-29449-9 DO - 10.1038/s41598-018-29449-9 ID - Yamamoto2018 ER - TY - JOUR AU - Henriksen, G. AU - Fisher, D. R. AU - Roeske, J. C. AU - Bruland, Ø. S. AU - Larsen, R. H. PY - 2003 DA - 2003// TI - Targeting of osseous sites with α-emitting 223Ra: comparison with the β-emitter 89Sr in mice JO - J Nucl Med. VL - 44 ID - Henriksen2003 ER - TY - STD TI - Documentation regarding the calculation of release criteria for patients administered radiopharmaceutical agents: Safety Measures Division, Medication Safety Bureau, Ministry of Health and Welfare (Japanese Ministry); 1998. ID - ref5 ER - TY - STD TI - The fifth announcement from Science and Technology Agency (Japanese Ministry) about the amount of radioisotopes and others. (2000). ID - ref6 ER - TY - JOUR AU - Hosono, M. AU - Ikebuchi, H. AU - Nakamura, Y. AU - Yanagida, S. AU - Kinuya, S. PY - 2019 DA - 2019// TI - Introduction of the targeted alpha therapy (with radium-223) into clinical practice in Japan: learnings and implementation JO - Ann Nucl Med. VL - 33 UR - https://doi.org/10.1007/s12149-018-1317-1 DO - 10.1007/s12149-018-1317-1 ID - Hosono2019 ER - TY - JOUR PY - 2010 DA - 2010// TI - Lung cancer risk from radon and progeny and statement on radon. ICRP Publication 115 JO - Ann. ICRP VL - 40 ID - ref8 ER - TY - JOUR AU - Gosink, T. A. AU - Baskaran, M. AU - Holleman, D. F. PY - 1990 DA - 1990// TI - Radon in the human body from drinking water JO - Health Phys. VL - 59 UR - https://doi.org/10.1097/00004032-199012000-00016 DO - 10.1097/00004032-199012000-00016 ID - Gosink1990 ER - TY - JOUR PY - 2007 DA - 2007// TI - The 2007 Recommendations of the International Commission on Radiological Protection. ICRP Publication 103 JO - Ann ICRP VL - 37 ID - ref10 ER - TY - JOUR PY - 2007 DA - 2007// TI - Radiological Protection in Medicine. ICRP Publication 105 JO - Ann ICRP VL - 37 ID - ref11 ER -